Proyecto
 (2017)

Methylation of MGMT (o6-methylguanine-dna methyltransferase) in patients with glioblastoma multiforme.

Director; Matamala, José Manuel; Fernández, Rodrigo; Beatriz Fonseca

Más información

Fecha de publicación: 2017
Año de Inicio/Término: 2017-2019
Financiamiento/Sponsor: Fidum, Universidad Mayor
Notas: The Glioblastoma is among the primary brain tumors the highest malignancy and frequency. The methylation status of the MGMT promoter has been shown to be a powerful predictor of survival. We are evaluating the methylation status of the MGMT promoter by NGS in GBM samples of Chilean patients.